Aveo Pharmaceuticals, Inc.

Ancora Advisors LLC

Report date

9/30/2022

Quarter

2022 Q3

Filed

11/14/2022

Shares

46,169

Value ($000)

380

Weight

0.0%

2020 Q2 - 2022 Q3 (10 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q3	11/14/2022	380	0.0%	46,169	9/30/2022
2022 Q2	8/15/2022	303	0.0%	46,169	6/30/2022
2022 Q1	5/16/2022	258	0.0%	46,169	3/31/2022
2021 Q4	2/14/2022	217	0.0%	46,169	12/31/2021
2021 Q3	11/15/2021	285	0.0%	46,169	9/30/2021
2021 Q2	11/12/2021	304	0.0%	46,169	6/30/2021
2021 Q1	11/12/2021	295	0.0%	40,350	3/31/2021
2020 Q4	11/12/2021	210	0.0%	36,350	12/31/2020
2020 Q3	11/12/2021	216	0.0%	36,350	9/30/2020
2020 Q2	11/12/2021	187	0.0%	36,350	6/30/2020